Empowering Women's Health: Navigating Global Regulatory Challenges and Innovations

Recent scientific advancements and regulatory updates have significantly impacted the women's health sector globally. Data indicates that health inequities lead to women spending 25 percent more time in poor health, with implications to society. These advancements include regulations on clinical trials and innovations such as digital therapeutics paving the way for personalized, accessible and inclusive care. Additionally, new therapies and solutions for menopause and other women's health issues are being developed, offering opportunities for better management of these conditions. This session will provide an exploration of the regulatory environment for women's health products across various categories, including drugs, medical devices, non-prescription medicines, and dietary supplements. Participants will gain an understanding of the scientific landscape and regulatory challenges and opportunities in this sector. Further, they will be equipped with practical knowledge and strategies to navigate the complex regulatory landscape, fostering innovation in women's health products and help enable opportunities to close the health equity gap.